GPCRs represent a vast and diverse family of membrane proteins that translate extracellular cues into intracellular responses, influencing myriad physiological processes. Among them, the Class B1 receptors like GHRHR have remained notably challenging to characterize due to their inherent conformational plasticity. Previous attempts to capture their dynamic states often resulted in static structural snapshots, failing to convey the receptor’s true functional repertoire. This latest research surmounts those limitations by resolving GHRHR structures in three pivotal functional states: the ligand-free (apo) state, an active state stimulated by the allosteric small-molecule agonist PCO371, and the inactive state bound by the peptidic antagonist MIA-602.

The cryo-EM maps, bolstered by MD simulations, illuminate the distinct conformations adopted by GHRHR under varying ligand conditions. In the ligand-free apo state, the receptor appears poised for activation yet does not spontaneously signal, embodying a flexible scaffold that primes it for external stimuli. Contrastingly, PCO371 binds at an intracellular allosteric site, a previously underappreciated pocket distinct from the conventional extracellular orthosteric binding domain. This binding mechanism uniquely stabilizes the receptor’s active conformation from within the cell, revealing the molecular basis for biased agonism—preferential activation of selective intracellular signaling pathways.

This allosteric modulation challenges canonical GPCR activation paradigms, where ligand engagement at the extracellular face traditionally triggers intracellular changes through transmembrane helix rearrangements. By establishing intracellular binding, PCO371 effectively rewires receptor signaling outcomes, offering a template for designing precision therapeutics that fine-tune GHRHR activity with enhanced efficacy and reduced side effects. Such biased agonists could revolutionize interventions for growth hormone deficiencies, dwarfism, and metabolic disorders linked to receptor dysregulation.

Equally compelling is the structural characterization of the inactive GHRHR when bound to MIA-602, a peptide-based antagonist. Here, the receptor’s conformation is locked by the engagement of a conserved “HETY” motif that acts as a molecular linchpin. This motif’s stabilization prevents the receptor from undergoing the conformational rearrangements necessary for coupling with the G_s protein, effectively silencing its downstream signaling. The atomic details of this antagonist-induced blockade enrich our understanding of how selective inhibitors can impose conformational constraints on GPCRs, a strategy that could be harnessed to mitigate pathologies such as hormone-dependent tumors and acromegaly.

This research also underscores the power of integrating cryo-EM structural data with computational simulations. While cryo-EM captures high-resolution static images of receptor states, MD simulations provide a dynamic view of the receptor’s conformational transitions and ligand-induced adaptations over time. This combined approach enables a holistic visualization of GHRHR’s signaling cycle, encompassing activation, modulation, and inhibition phases in physiologically relevant contexts.

From a drug development perspective, the revelations of this study offer a transformative framework. The ability to discern precise ligand binding sites—both orthosteric and allosteric—and their consequent structural effects enables rational design of molecules tailored to manipulate the receptor with unprecedented specificity. It opens pathways to develop next-generation therapeutics that exploit biased signaling mechanisms, offering enhanced therapeutic windows, reduced adverse reactions, and customized regulation of receptor activity.

Moreover, understanding the structural plasticity of GHRHR informs broader GPCR research, as many receptors may share similar allosteric sites or regulatory motifs amenable to selective targeting. This knowledge extends beyond growth hormone signaling, potentially impacting treatment strategies for a wide spectrum of diseases mediated by GPCR dysfunction.

The implications of this work resonate strongly in fields such as endocrinology, oncology, and metabolic medicine. Precision targeting of GHRHR could remedy growth hormone deficiencies and genetic dwarfism with refined agonists while providing potent antagonists for controlling hormone-sensitive cancers and related disorders. Ultimately, this study shifts the paradigm from viewing GPCR signaling as binary “on-off” states toward appreciating a continuum of ligand-specific conformations that modulate cellular outcomes.

This research epitomizes how cutting-edge structural biology techniques catalyze breakthroughs in understanding complex membrane proteins. As the medical community increasingly recognizes the therapeutic potential residing in GPCR allosteric sites and conformational dynamics, such high-resolution insights become invaluable blueprints for innovation. These findings embolden a new era of GPCR-targeted drug discovery grounded in molecular precision, signaling bias, and receptor conformational plasticity.

In conclusion, the comprehensive structural elucidations of human GHRHR detailed in this study represent a significant leap forward in receptor biology and pharmacology. By revealing how specific ligands stabilize distinct receptor states, the research not only deepens our mechanistic understanding but also propels the development of specialized therapeutics with the promise of improved clinical outcomes. This fusion of cryo-EM and molecular simulations exemplifies the future of dynamic structural biology—capturing proteins in action to unlock their full therapeutic potential.

Article Title: Structural adaptation associated with signaling preference at the human GHRHR

News Publication Date: 18-Mar-2026

Web References: 10.1093/procel/pwag016

Image Credits: HIGHER EDUCATION PRESS

Keywords: Growth Hormone-Releasing Hormone Receptor, GHRHR, GPCR, cryo-EM, molecular dynamics, allosteric agonist, PCO371, antagonist, MIA-602, biased signaling, structural biology, drug discovery

The journey began with the expression and purification of G protein heterotrimers using Trichoplusia ni-derived Tni cells, engineered with viral constructs encoding Gα, Gβγ subunits, and the chaperone Ric-8a. The process involved meticulous detergent-based solubilization protocols, optimizing extraction conditions to preserve native-like conformations essential for structural integrity. Crucially, biotinylated Tris-NTA conjugated to Ni²⁺ ions enabled targeted affinity purification, setting the stage for high-fidelity single-molecule fluorescence experiments.

Parallel efforts were devoted to isolating NTSR1 from Sf9 insect cells using a baculovirus system. Membrane fractions were systematically solubilized with gentle detergents, including lauryl maltose neopentyl glycol (LMNG) and cholesterol hemisuccinate (CHS), reflecting a membrane-mimetic environment supportive of receptor stability. Imidazole-based affinity chromatography via TALON resin was combined with size-exclusion chromatography to yield milligram quantities of homogenous receptor, critical for downstream complex assembly and high-resolution cryo-EM.

A pivotal advance involved assembling the NTSR1–G protein complex by incubating ligand-bound receptor with an optimized molar excess of G proteins, followed by apyrase-mediated GDP depletion to stabilize nucleotide-free states. The application of the M1 Flag affinity system allowed rigorous separation of receptor–G protein assemblies from excess subunits, with careful detergent modulation ensuring complex integrity. Subsequent size-exclusion steps refined sample homogeneity to a degree suitable for cryo-EM structural elucidation.

Innovatively, the team reconstituted NTSR1-Gi1 complexes into nanodiscs—lipid bilayer mimetics composed of POPC and POPG phospholipids encased within MSP1D1 scaffold proteins. This native-like environment preserved transmembrane signaling domains and facilitated physiologically relevant functional assays. Following detergent removal with Bio-Beads, nanodisc-embedded complexes were purified and concentrated for cryo-EM, representing a methodological milestone in membrane protein structural biology.

Cryo-EM data acquisition was performed on state-of-the-art Titan Krios microscopes equipped with direct electron detectors and energy filters, refined by precise sample grid preparation on ultrastable gold supports. Time-resolved freezing captured distinct activation states at 6- and 20-second intervals post-GTP application, enabling a dynamic dissection of conformational changes. Data processing harnessed the power of cryoSPARC, integrating nonlinear refinement algorithms, heterogeneous classification, and 3D variability analyses to resolve subtle structural heterogeneity within receptor–G protein populations.

Subsequent model building relied on existing high-resolution templates of NTSR1-Gi complexes, supplemented by manual refinement to accommodate novel conformations revealed by time-resolved datasets. The incorporation of molecular dynamics simulations provided an atomic-level temporal viewpoint, allowing assessment of interaction networks and domain motions. Notably, simulations included realistic lipid compositions with cholesterol hemisuccinate, ensuring biophysical relevance—a key factor for proper modulation of GPCR function.

Biophysical assays utilizing kinetic bioluminescence resonance energy transfer (BRET) in mammalian HEK 293 cells quantified G protein activation dynamics across receptor variants and Gα subtypes, underscoring the functional consequences of receptor structural states. Mutations in intracellular loops were systematically investigated, revealing key determinants of subtype specificity and signal bias—a critical insight for drug discovery.

Complementary single-molecule fluorescence experiments leveraged custom-built prism-based total internal reflection fluorescence microscopy. Labeling of NTSR1 with fluorescent probes allowed real-time tracking of receptor–G protein dissociation upon GTP addition. Sophisticated microfluidic controls enabled rapid buffer exchanges, capturing kinetic profiles with exquisite temporal resolution. Analyses distinguished photobleaching effects from functional dissociation events via multi-exponential fitting, providing quantitative parameters for G protein engagement lifetimes.

Collectively, this multifaceted approach illuminates the dynamic interplay between NTSR1 and its cognate G proteins, articulating how transient conformations dictate promiscuous yet selective signaling outcomes. The findings challenge traditional static views of GPCR activation, highlighting an adaptable interface that balances affinity and versatility. This paradigm shift promises to inspire design of allosteric modulators or biased agonists with refined therapeutic indices.

Furthermore, the state-of-the-art methodologies employed—ranging from detergent-based protein purification to nanodisc reconstitution, time-resolved cryo-EM, and single-molecule kinetic measurements—represent a comprehensive toolbox for investigating membrane protein dynamics at unprecedented scales. Such integrative structural biology frameworks will accelerate delineation of complex signaling networks across physiological and pathological contexts.

By capturing “snapshots” of NTSR1’s conformational ensemble, researchers have charted a roadmap to decoding GPCR heterotrimer selectivity, informing medicinal chemistry efforts to exploit receptor G protein promiscuity. Considering the ubiquity of GPCRs as drug targets, these breakthroughs hold vast implications for developing more efficacious and safer therapeutics targeting neuropeptide, opioid, and other receptor families exhibiting signaling plasticity.

As the frontier of dynamic structural biology advances, this study exemplifies the synergy between high-resolution imaging, computational modeling, and biophysical probing—collectively enabling a holistic understanding of membrane receptor functionality. Future investigations may leverage these insights to unravel the temporal codes governing receptor-mediated signal transduction, ultimately bridging molecular mechanisms with physiological outcomes.

Subject of Research: Molecular mechanisms underlying GPCR (NTSR1) G protein subtype promiscuity and dynamics.

Article Title: Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity.

Article References:
Vo, A.A., Modak, A., Lu, S. et al. Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity. Nature (2026). https://doi.org/10.1038/s41586-026-10120-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-026-10120-7